Symbiotic Healthcare was founded by North Shore-LIJ Health System infectious disease specialist Bruce Hirsch, MD, and immunologist Gerard Honig. The company’s capsule holds the processed matter and can be refrigerated for later use.
In a preliminary test including 23 patients, the pills resulted in an 87 percent cure rate.
The company is currently self-funded, but its founders are looking for financial backing, according to the report.
More Articles on C. difficile:
NIH starats clinical trial for C. diff drug
8 things to know: FMT for C. diff infection safe in immunocompromised patients
Synthetic Biologics forms clinical advisory board for C. diff prevention product
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.